Chapter 246 How Much Does It Cost to Get Technology Transfer?
The discovery of a special drug for AIDS has attracted great attention from all over the world.
With the convening of the press conference, countless people were rejoicing and looking forward to it.
However, when Zhang Jianfu answered reporters' questions, he was vague about the source of technology, which made some people very dissatisfied.
Of course, this does not affect the authority of the press conference.
And with the press conference, the news that the AIDS drug is about to be released has really spread all over the world.
In addition to the domestic news reports, the Wall Street Journal, the New York Times, The Guardian and many other foreign heavyweight media have successively carried out large-scale reports.
[AIDS is saved]
[AIDS drug is coming soon]
[The savior of the world's 37.9 million people living with HIV is here]
【……】
Within 48 hours after the press conference, more than 300 medical institutions and units from more than 100 countries and regions around the world submitted applications for cooperation to Oneworld.
At the same time, the relevant departments of China have also sent people to contact and negotiate.
You must know that the invention of AIDS drugs by Universal Biotech is not only about their company's business, but also involves national interests.
For example, China and the EU signed the "China-EU Science and Technology Cooperation Agreement" in 98, which includes medical technology cooperation.
However, there is no relevant agreement on the United States side, and Universal Biotech cannot be sold to the United States without permission, and the United States must come up with some equivalent exchange technology or medical equipment in order to obtain the right to import AIDS specific drugs.
Now the relevant departments have come over, in addition to informing them of the relevant rights and obligations, there is also an important matter, which is to accompany the people of the EU Framework Programme Committee to come and discuss the issue of technology licensing.
At two o'clock in the afternoon of the 27th, Block A, Hengfeng Building, Jinhu District.
The spacious and luxurious conference room was full of people, in addition to leaders and entourages from the Ministry of Science and Technology, the W Health Commission, the government and other relevant departments, there were also a group of foreigners with high noses and blue eyes.
These are the commissioners of the EU Framework Programme Committee.
The main ones are the Commission's Director-General, Fast and Deputy Commissioner, Lucia.
"You cosmos creatures are really good. ”
"Thank you for the praise from the leader, we still have a lot to do and need to learn and improve. ”
"Mr. Zhang, let me introduce you, this is Mr. Fast, the Director-General of the European Framework Commission, and this is Ms. Lucia, the Deputy Commissioner. ”
"Hello hello ~ "
"Hello ......"
After some greetings, Zhong Y and the local government leaders were all smiling and chatting over tea, as for specific matters, naturally there were special people to talk to Huanyu Biotech privately, and they didn't need to worry about it.
And the people in the EU Framework Programme Committee have even less to do with them.
The agreement was signed by the previous leader, and the benefits and honors were also taken up by the predecessor, and they brought people from the EU over just to do a little bit of duty, as for whether the people of the EU and Huanyu can negotiate a result, it is none of their business.
Besides, the international situation is volatile, even the United Kingdom has left the European Union, and the agreement signed 20 years ago is now only a superficial one, and in fact has no binding force on both sides at all.
Director General, Fast, who had gray hair and a beautiful beard, pushed the black-framed glasses on the bridge of his nose and said straight to the point: "Mr. Zhang, we came here this time mainly to obtain authorization for the technology and formula of AIDS specific drugs. ”
Zhang Jianfu is of course aware of the scientific and technological cooperation agreement between China and the EU, so what he said about Fast is not surprising.
He happily agreed, "Yes!"
It was the turn of Director General Fast to be surprised, he originally thought that Zhang Jianfu would refuse, but he didn't expect the other party to agree so readily, his heart was suddenly happy, and the corners of his mouth began to curl.
But before the smile on Fast's face could fully unfold, Zhang Jianfu followed closely: "But it's ......."
Director General's heart suddenly tightened, and he secretly said "here", with a slight smile on his face, and took the initiative to say: "Mr. Zhang, please rest assured, we will give some financial compensation." ”
Zhang Jianfu changed his words and asked, "How much?"
Fast: "1 million euros. ”
Zhang Jianfu said with a smile: "Mr. Fast, as far as I know, the EU Sixth Framework Plan has an annual basic research funding of up to 700 million euros, of which about 30 million euros are spent on HIV research every year.
This cost is borne by each EU member state in proportion to its GDP.
You have absorbed all this money internally, but you have not provided us with a penny of research funds.
Do you think it's appropriate to give us 1 million euros like a beggar and just want to take away our technological achievements?"
An embarrassed look appeared on Fast's face, "Uh......"
Deputy Commissioner Lucia, who was wearing a black skirt and meat stockings, immediately said: "Mr. Zhang, since you are familiar with the operation of our committee, you should know that we are a non-profit unit, and 1 million euros is compensation, not technology purchase, and I hope you understand this." ”
Zhang Jianfu: "Of course I do! But the drugs produced are not free, are they? Moreover, most of the original drugs imported by China are self-funded, isn't it a fact? So you don't need to tell me anything about non-profit units, we all know what is going on. ”
Lucia frowned and said, "But you must know that China and the EU have signed an agreement, and you must unconditionally provide us with technical formulas. ”
Zhang Jianfu smiled and said, "Ms. Lucia, if you say that, we won't have anything to talk about." Why don't you go back and talk about it?"
Lucia's face looked a little unpleasant, and she frowned and stopped talking.
Fast asked, "Mr. Zhang, can you tell me how much it costs to get technology transfer?"
Zhang Jianfu said very simply: "Provide us with 30 million euros of R&D funds every year for three years. In addition, for each drug sold, we receive a share of 2,000 euros from sales. How's that, it's not too much, is it?"
Fast: "......"
Lucia: "......"
Isn't that excessive?
It's insane.
Not only does it have a licensing fee of 90 million, but also a drug has to have a sales share of 2,000 euros, which is so dark that it is boundless.
According to this calculation, a medicine will be sold for at least 5,000 euros to be able to return to its original cost, how many people can afford this price?
Fast stood up and said, "I'm sorry, let's go first." ”
Zhang Jianfu then stood up and said with a smile: "Okay then, but seriously, Mr. Fast, the price we offered is already very fair." ”
Fast was noncommittal.
……
Biologics Universe Laboratories.
In the office, the secretary Chu Lin was reporting the results of the negotiations to Zhou Wen.
Mr. Zhang said that the EU is likely to put pressure on us through the government, but he has already sent someone to communicate in advance, and the problem is not big, and now he is still a little worried about the efficacy of the drug and hopes to start clinical trials as soon as possible. ”
Zhou Wen said with a smile: "You tell him, there is no need to worry about the efficacy! As for the phase I clinical trial, it will be about the same in the middle of next month." ”
"Okay, I got it!" Chu Lin packed up the papers, and then asked, "Are you okay?"
Zhou Wen flipped through the notepad and said, "It's okay, you go back!"
"Hmm!"
After Chu Lin left, Zhou Wen got up and went to the second phase of the experimental building, the AIDS Research Institute.
In the laboratory, a group of drug research experts were all excited.
Because the drug has already passed the therapeutic experiment, it directly skips the [drug discovery stage], that is, the painstaking experimental steps such as drug source, chemical synthesis, target screening, lead screening, etc., and directly starts [preclinical research].
That is, safety evaluation.
Seeing Zhou Wen coming, Dr. Wang Rong, the person in charge, said excitedly: "After the preliminary test, the safety meets the experimental requirements. ”
Although human trials have been carried out in Botswana, safety is guaranteed.
But after all, it is a private experiment, and it is impossible to conduct clinical trials without testing and certification from authoritative institutions.
Now, clinical trials are just one step away.
The most important thing is that the result is already predestined, and that's the most important thing.
Zhou Wen nodded.
After talking to Dr. Wang Rong, he left the AIDS Institute and went to the Anti-Allergy Research Institute next door.
Chen Ruobing is immersed in front of the computer researching compounds.
This is the anti-allergic cough of her previous research institute, and the target was discovered by Zhou Wen for her, and she has published many papers for it, which has been highly recognized by the medical community at home and abroad.
Of course, the discovery of drug target data does not mean that a drug can be developed, which is not a concept.
Because it is necessary to carry out "synthesis of compounds" and "screening of active compounds" later......
Under normal circumstances, the discovery of drug target data is just the first step in a long march.
But now with the help of Zhou Wen, a pharmaceutical genius, she no longer walked the Long March on foot, but drove a car and ran 120 miles forward......